Simple but Not Easy with Jake Auchincloss

America versus Alzheimer's

A bipartisan call in Washington urges the United States to make curing Alzheimer’s a flagship scientific enterprise. The proposal calls for billions in basic brain research, Medicare coverage for early diagnosis and preventive treatment starting at age 50, and parity in market exclusivity between pills and injectables. It also recommends a coordinated federal clinical‑trial network to speed drug development. With an estimated 15 million Americans affected by 2050 and a $1 trillion annual cost, the stakes are economic and humanitarian.